May 27, 2026
5 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Sustained-release insert provides durable retinal disease control
FORT LAUDERDALE, Fla. — An intravitreal insert provides durable control of multiple retinal diseases, according to a presentation at Retina World Congress. Ashkan M. Abbey, MD, FASRS, FAAO, told Healio that EYP-1901, also known as Duravyu (vorolanib intravitreal insert, EyePoint Pharmaceuticals), works by inhibiting the intracellular pan-VEGF receptor as well as the PDGF receptor while
599 words~3 min read
